The Fortis Cancer Institute, Manesar, consolidates a wide spectrum of advanced treatment technologies and specialised interventions, designed to deliver personalised and outcomes-focused cancer care. The institute is equipped with cutting-edge healthcare infrastructure, including the Da Vinci Xi robotic surgery system, Hyperthermic Intraperitoneal Chemotherapy, Pressurized Intraperitoneal Aerosolized Chemotherapy, Hepatic Artery Infusion Pump chemotherapy, fluorescence-guided breast surgery, and oncoplastic breast surgery. It also features a dedicated lymphedema clinic and organ-specific oncology programmes tailored to individual patient needs.
The institute places strong emphasis on precision oncology, supported by a multi-disciplinary tumor board. It integrates modern treatment approaches such as immunotherapy, targeted therapy, molecular oncology, and genetic counseling and testing, enabling highly customised treatment decisions for complex cancer cases.
Dr. Vinay Samuel Gaikwad, Senior Director, Surgical Oncology, Fortis Hospital, Manesar, stated that the future of oncology lies in combining surgical precision with personalised treatment pathways. He emphasised that the institute focuses on utilising advanced technologies to make cancer treatment more targeted, less invasive, and more effective for patients.
Dr. Pooja Babbar, Consultant, Medical Oncology, highlighted that cancer care is no longer defined by a single treatment approach. She noted that integrating molecular diagnostics, targeted therapies, and collaborative decision-making is creating a comprehensive model of care that improves both outcomes and quality of life.
Dr. Mansi Chowhan, Senior Consultant, Surgical Oncology, stressed that modern oncology enables unique treatment for each cancer case. She explained that genetic testing, immunotherapy, and organ-specific expertise allow for treatment strategies that are significantly more precise than conventional methods.
Abhijit Singh, Facility Director, Fortis Hospital Manesar, described the launch as a crucial step in bringing world-class cancer care closer to patients in Manesar and surrounding regions. He noted that with cancer cases rising globally, there remains a critical gap in accessible, high-quality treatment, and the new institute aims to bridge this gap through advanced technology, multidisciplinary expertise, and leading oncologists.
Fortis Healthcare Limited, a leading integrated healthcare delivery service provider in India, operates hospitals, diagnostics, and day care specialty facilities. The company currently manages 36 healthcare facilities, including joint ventures and operations and management units, across 12 states and union territories. Its network includes over 6,000 operational beds and 400 diagnostic laboratories.
The launch of the Fortis Cancer Institute in Manesar marks a pivotal development in expanding access to advanced oncology care, reinforcing the role of technology, precision medicine, and integrated expertise in transforming cancer treatment outcomes.
About The Author
Comment List